Showing results (1131-1140 of 2,007) with videos related to
Sort By:
Pageof 201
Journal of Clinical Lipidology|September 29, 2016
US physician practices for diagnosing familial hypercholesterolemia: data from the CASCADE-FH registryZahid S Ahmad, Rolf L Andersen, Lars H Andersen, et al.Journal of Clinical Lipidology|September 29, 2016
Body mass index and glycemic control influence lipoproteins in children with type 1 diabetesShalini Vaid, Lynae Hanks, Russell Griffin, et al.Journal of Clinical Lipidology|September 29, 2016
An evidence-based analysis of the National Lipid Association recommendations concerning non-HDL-C and apoBAllan D Sniderman, Peter P Toth, George Thanassoulis, et al.Journal of Clinical Lipidology|April 11, 2017
Lipoprotein-X in cholestatic patients causes xanthomas and promotes foam cell formation in human macrophagesLuka Suzuki, Satoshi Hirayama, Mariko Fukui, et al.Journal of Clinical Lipidology|April 11, 2017
Individual omega-9 monounsaturated fatty acids and mortality-The Ludwigshafen Risk and Cardiovascular Health StudyGraciela E Delgado, Bernhard K Krämer, Stefan Lorkowski, et al.Journal of Clinical Lipidology|April 11, 2017
Investigating the prevalence, predictors, and prognosis of suboptimal statin use early after a non-ST elevation acute coronary syndromeRichard M Turner, Peng Yin, Anita Hanson, et al.Journal of Clinical Lipidology|April 11, 2017
Changes in low-density lipoprotein size phenotypes associate with changes in apolipoprotein C-III glycoforms after dietary interventionsSaulo Mendoza, Olgica Trenchevska, Sarah M King, et al.Journal of Clinical Lipidology|April 11, 2017
Cost-effectiveness of a cascade screening program for the early detection of familial hypercholesterolemiaPablo Lázaro, Leopoldo Pérez de Isla, Gerald F Watts, et al.Journal of Clinical Lipidology|April 11, 2017
Lipoprotein-X disease in the setting of severe cholestatic hepatobiliary autoimmune diseaseRobert E Heinl, Heather M Tennant, John C Ricketts, et al.Journal of Clinical Lipidology|April 11, 2017
Low-density lipoprotein receptor-negative compound heterozygous familial hypercholesterolemia: Two lifetime journeys of lipid-lowering therapyReyhana Yahya, Monique T Mulder, Eric J G Sijbrands, et al.Pageof 201